米国市場銘柄情報

BLCO ボシュロム

銘柄追加

13.860
+0.120+0.87%

終値 05/02 16:00 ET

13.950
+0.090+0.65%

市場後 17:24 ET

48.71億時価総額-14437直近PER

ボシュロムに関するコメント

ログインコメントを投稿

Meltyy

02/22 11:25

Why Is Emergent BioSolutions (EBS) Stock Up 70% Today?

In today’s market, one of the biggest winners generating outsized interest is $エマージェント・バイオソリューションズ(EBS.US)$ . This mid-cap biotech company remains a unique turnaround story for investors, and many appear to be placing their bets on this company to come out of the pile as a key winner. Indeed, EBS stock has surged over 70% higher on some intriguing news this afternoon.
The company’s turnaround efforts appear to be receiving a jolt today, wit...

Mett

2022/09/14 22:29

$ボシュロム(BLCO.US)$
EP 17.19
SL 16.49

Analysts Notebook

2022/09/12 21:36

コラムUS Top Rating Updates on 9/12: ADBE, OXY, RBLX, UNP and More

Upgrades
• $Argo Group International(ARGO.US)$ : Compass Point Upgrades to Buy from Neutral - PT $28.50
• $アパッチ(APA.US)$ : Citigroup Upgrades to Buy from Neutral - PT $58 (from $40)
• $カナディアン・ナショナル・レールウェイ(CNI.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $128)
• $カナディアン・パシフィック・カンザス・シティ(CP.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $87 (from $85)
• $カーペンター・テクノロジー(CRS.US)$ : Cowen Upgra...

Analysts Notebook

2022/09/09 20:00

コラムUS Top Rating Updates on 9/9: MMM, REGN, ENPH, PSNY and More

Analysts Notebook

2022/07/26 19:32

コラムTop upgrades and downgrades on 7/26: UBS, ROKU, PARA, CHWY and more

Upgrades
• $Zymergen(ZY.US)$ : JPMorgan Upgrades to Neutral from Underweight
Downgrades
• $チューイー(CHWY.US)$: Wedbush Downgrades to Neutral from Outperform - PT $44 (from $35)
• $パラマウント・グローバル(PARA.US)$: Goldman Sachs Downgrades to Sell from Buy - PT $20 (from $37)
• $ロク(ROKU.US)$: Wolfe Research Downgrades to Underperform from Peerperform - PT $77
• $UBSグループ(UBS.US)$: BofA Securities Downgrades to Neutral from Buy - P...

Jamesim

2022/07/25 20:52

How does your family feel about your trading?

There is no objection, nor complete approval, only a golden sentence: be careful in everything, don't invest too much, pay attention to investment.

Does your family support you in trading?

Support, but of course there is persuasion not to invest too much money, learn from experience first.

If they do, in what ways? How did that help you?

Because my father also invested, due to the difference in the number of shares traded in each lot of US s...

Does your family support you in trading?

Analysts Notebook

2022/06/24 20:18

コラムTop upgrades and downgrades on 6/24: CLR, MRO, SGEN, FUL and more

Upgrades
• $アメリカンウォーターワークス(AWK.US)$ : Janney Upgrades to Buy from Neutral
• $ベクトン・ディッキンソン(BDX.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $275
• $アルトリア・グループ(MO.US)$ : Morgan Stanley Upgrades to Equalweight from Underweight - PT $43 (from $47)
• $ミドルセックス・ウォーター(MSEX.US)$ : Janney Upgrades to Buy from Neutral
• $インドネシア・エネルギー(INDO.US)$ : Noble Capital Upgrades to Outperform from Market Perform - PT...

Analysts Notebook

2022/06/06 19:01

コラムTop upgrades and downgrades on 6/6

Upgrades
• $アルダ・メタル・パッケージング(AMBP.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $9
• $アメリカン・エキスプレス(AXP.US)$ : Edward Jones Upgrades to Buy from Hold
• $クラウドストライク(CRWD.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $215 (from $195)
• $ルルレモン・アスレティカ(LULU.US)$ : Bernstein Upgrades to Market Perform from Underperform - PT $300 (from $260)
• $レスメド(RMD.US)$ : RBC Upgrades to Outperform from Sector Perform - PT $244 (from $...

Analysts Notebook

2022/05/31 22:47

コラムAnalysts' screen on BLCO, SNAP, TSLA, ZM and more

GOLDMAN SACHS
•$ボシュロム(BLCO.US)$ Goldman Sachs analyst Amit Hazan initiated coverage of Bausch + Lomb with a Neutral rating and $22 price target, implying 22% upside potential. The analyst sees Bausch + Lomb's current offering and pipeline as positioning it well to maintain or expand share in the "attractive and durable' eye care market.
•$スチール・ダイナミクス(STLD.US)$ Goldman Sachs analyst Emily Chieng downgraded Steel Dynamics to Neutral...

Analysts Notebook

2022/05/31 18:31

コラムTop upgrades and downgrades on 5/31

Upgrades
• $グラブ・ホールディングス(GRAB.US)$: Bernstein Upgrades to Outperform from Market Perform - PT $3.04
• $リンデ(LIN.US)$: Evercore ISI Upgrades to Outperform from In Line - PT $355
• $Magellan Midstream(MMP.US)$: Wells Fargo Upgrades to Overweight from EqualWeight - PT $56 (from $54)
• $マーキュリー・システムズ(MRCY.US)$: Baird Upgrades to Outperform from Neutral - PT $72 (from $56)
• $ニューリックス・セラピューティクス(NRIX.US)$: Wells Fargo Upgrades to Overweight from EqualWeight - PT...

まだコメントはありません

分析

アナリスト評価

データなし

目標株価

データなし

ホット

米国株

総合人気